CAMBRIDGE, Mass., March 12, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it will host an Analyst and Investor Day on April 11, 2018 in New York City from 8:30 a.m. – 11:00 a.m. ET. Vericel executives will provide business updates and facilitate discussions with surgeon thought leaders who currently use Vericel products in their practices. Also speaking will be world champion swimmer, best-selling author, five-time Olympian and MACI® (autologous cultured chondrocytes on porcine collagen membrane) patient Dara Torres.
The presentation will be live webcast at http://investors.vcel.com/events-presentations. For those not available to listen to the live broadcast, a replay will be archived until April 10, 2019 and available at http://investors.vcel.com/events-presentations. For more information or to RSVP please contact Kelly Mueller at [email protected].
About Vericel Corporation
Vericel is a leader in advanced cell therapies for the sports medicine and severe burn care markets. The company markets two advanced cell therapy products in the United States. MACI® is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. For more information, please visit the company's website at www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel Corporation. © 2018 Vericel Corporation. All rights reserved.
(vcel-corp)
Global Media Contacts:
David Schull
Russo Partners LLC
+1 212-845-4271 (office)
+1 858-717-2310 (mobile)
[email protected]
Karen Chase
Russo Partners LLC
+1 646-942-5627 (office)
+1 917-547-0434 (mobile)
[email protected]
Investor Contacts:
Chad Rubin
Solebury Trout
[email protected]
+1 (646) 378-2947
Lee Stern
Solebury Trout
[email protected]
+1 (646) 378-2922


Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Amazon Explores AI Content Marketplace With Media Publishers
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Anta Sports Expands Global Footprint With Strategic Puma Stake
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



